The RSI Indicator for RHHVF moved out of oversold territory on November 21, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In of the 22 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on RHHVF as a result. In of 117 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for RHHVF just turned positive on November 29, 2024. Looking at past instances where RHHVF's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RHHVF advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .
RHHVF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RHHVF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for RHHVF entered a downward trend on December 02, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.987) is normal, around the industry mean (5.632). P/E Ratio (19.342) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (4.002) is also within normal values, averaging (3.004). Dividend Yield (0.034) settles around the average of (0.164) among similar stocks. P/S Ratio (3.557) is also within normal values, averaging (3.643).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RHHVF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RHHVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
Industry PharmaceuticalsMajor
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RSEGX | 61.71 | N/A | N/A |
Victory RS Small Cap Growth A | |||
NSBFX | 63.77 | -0.36 | -0.56% |
Nuveen Dividend Growth R6 | |||
FWMNX | 17.76 | -0.12 | -0.67% |
Fidelity Advisor Women's Leadership I | |||
ACCOX | 8.47 | -0.06 | -0.68% |
American Century International Val C | |||
BKDEX | 10.24 | -0.07 | -0.68% |
BlackRock Defensive Advantage EM K |
A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.
Ticker / NAME | Correlation To RHHVF | 1D Price Change % | ||
---|---|---|---|---|
RHHVF | 100% | +1.90% | ||
RHHBY - RHHVF | 65% Loosely correlated | +0.84% | ||
JNJ - RHHVF | 31% Poorly correlated | +1.78% | ||
NVS - RHHVF | 27% Poorly correlated | +1.36% | ||
AZN - RHHVF | 26% Poorly correlated | +1.43% | ||
RHHBF - RHHVF | 25% Poorly correlated | N/A | ||
More |